NIFTY - REPORT - 16 November Equity Research Lab
NIFTY - REPORT - 16 November Equity Research Lab
NIFTY - REPORT - 16 November Equity Research Lab
uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
16 November 2016
wertyuiopasdfghjklzxcvbnmqwertyui
Prepared by: Meenakshi Pal
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
th
NIFTY FUTURE
NIFTY FUTURE :
PIVOT :8183
R1:8243
S1:8079
R2:8347
S2:8020
R3:8407
S3:7916
INDEX OUTLOOK
NIFTY FUTURE: Indian Market succumbed to more selling on Tuesday as the demonetization effect and
weak earnings drove the Sensex lower by 565 points and the Nifty below 8100 intraday. Strengthening
of bond yields and US dollar on US president-elect Donald Trump policy also weighed on market
sentiment. Equity benchmarks closed below their 200-daily moving average. Sensex tanked 514.19
points or 1.92 percent to 26304.63, the lowest closing level since May 25, taking the total loss for two
consecutive days to 1200 points. Nifty was down 187.85 points or 2.26 % to close at 8108.45 after
hitting an intraday low of 8093.20. demonetization will be negative for equities in short term, adding
that the move is a positive for bond and currency markets. Besides, demonetization will help increase
deposit growth of banks significantly.
WWW.EQUITYRESEARCHLAB.COM
STRATEGY: Sell Nifty Future below 8100 for the target of 8050 -8000 with the stop loss of 8180.
SECTORAL INDICES
INDEX (Spot)
SENSEX
NIFTY
NIFTYBANK
NIFTYIT
SUPPORT 2
25880
7975
18800
9200
CORPORATE NEWS
HPCL reported a sharp 66.6% QoQ fall in Net Profit in Q2FY17 at Rs. 701.3 Cr. The company reported a 7.1%
fall in Net Income from Operations at Rs. 47,822.5 Cr in Q2 as against Rs. 51,661 Cr in the previous quarter.
EBITDA fell 65.2% sequentially to Rs. 1,261 Cr and margins contracted by 442 bps to 2.6% in Q2.
Tata Motors reported a significant drop in Net Profits to Rs. 848 Cr in Q2, as against Rs. 1,740 Cr in the
corresponding quarter last year. Total Consolidated Revenues rose 6.7% to Rs. 67,999.7 Cr as against Rs.
62,647.2 Cr previously. Hedging losses worth Rs. 3,510 Cr affected the bottom line severely. JLR revenues for
Q2 rose 23.2% to 5.95 billion pounds, and PAT improved at 244 million pounds. The companys domestic unit
reported a fall in Net Revenues to Rs. 11,406 Cr and a net loss of Rs. 289 Cr.
GAIL (India) reported a 180% rise in Net Profit to Rs. 924.7 Cr for Q2 against Rs.330.4 Cr in the corresponding
quarter last year. However, total Income from operations decreased 15.3% YoY to Rs.12,058.2 Cr during the
quarter against Rs.14,240.4 Cr previously. Total expenditure decreased to Rs.10,879.8 Cr in Q2 FY17 from over
Rs.13,731.3 Cr in Q2FY16.
WWW.EQUITYRESEARCHLAB.COM
Designation
E-mail ID
Research Head
Sr. Research Analyst
Sr. Research Analyst
[email protected]
[email protected]
[email protected]
DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.
Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.
Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.
ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.COM